Cytomegalovirus infections are associated with severe morbidity and mortality is patients at
risk for disease because of immune system disabilities; in particular, recipients of stem cell …

Cytomegalovirus (CMV) is a common viral pathogen that influences the outcome of liver
transplantation. In addition to the direct effects of CMV syndrome and tissue-invasive …

Late-onset cytomegalovirus (CMV) disease commonly occurs after discontinuation of
antiviral prophylaxis. We determined the utility of testing CD8+ T-cell response against CMV …

Oral ganciclovir prophylaxis and intravenous preemptive therapy are competitive
approaches to prevent cytomegalovirus (CMV) disease after renal transplantation. This trial …

Cytomegalovirus infection (CMV) in solid organ transplant recipients is a major clinical
problem. The aim of this study was to evaluate the incidence of CMV infection and its …

Rationale: Cytomegalovirus pneumonitis is one of the most prevalent opportunistic
infections after lung transplantation. Early studies reported that cytomegalovirus pneumonitis …

Cytomegalovirus (CMV) infection is a significant complication after kidney transplantation.
We examined the ability of RG7667, a combination of two monoclonal antibodies, to prevent …

Human cytomegalovirus (HCMV) is the leading viral cause of birth defects and organ
transplant rejection. The HCMV gH/gL/UL128/UL130/UL131A complex (Pentamer) is the …

Cytomegalovirus (CMV) is an opportunistic pathogen associated with significant morbidity
and mortality in immunocompromised hosts. Antiviral agents specifically targeting CMV were …

The precise impact of valganciclovir as preventive therapy for cytomegalovirus (CMV) in
solid organ transplant (SOT) recipients is not fully defined. Data from studies using …